Actinic keratosis (AKs or solar keratoses) are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It's most commonly found on the face, lips, ears, back of your hands, forearms, scalp or neck.
Actinic Keratosis Therapeutics Market contains market size and forecasts of Actinic Keratosis Therapeutics in global, including the following market information:
- Global Actinic Keratosis Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Actinic Keratosis Therapeutics Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Actinic Keratosis Therapeutics companies in 2021 (%)
The global Actinic Keratosis Therapeutics market was valued at 3408.9 million in 2021 and is projected to reach US$ 4786.1 million by 2028, at a CAGR of 5.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Topical Medications Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Actinic Keratosis Therapeutics include DUSA Pharmaceuticals, Novartis, Perrigo, LEO Pharma, Bausch Health, Taro Pharmaceutical, Galderma (Nestle), Biofrontera and Almirall and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Actinic Keratosis Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Actinic Keratosis Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Actinic Keratosis Therapeutics Market Segment Percentages, by Type, 2021 (%)
- Topical Medications
- Photodynamic Therapy
- Destructive Treatment
Global Actinic Keratosis Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Actinic Keratosis Therapeutics Market Segment Percentages, by Application, 2021 (%)
Global Actinic Keratosis Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Actinic Keratosis Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Actinic Keratosis Therapeutics revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Actinic Keratosis Therapeutics revenues share in global market, 2021 (%)
- Key companies Actinic Keratosis Therapeutics sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Actinic Keratosis Therapeutics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- DUSA Pharmaceuticals
- Novartis
- Perrigo
- LEO Pharma
- Bausch Health
- Taro Pharmaceutical
- Galderma (Nestle)
- Biofrontera
- Almirall
- Tolmar Pharmaceutical
Industry Market Size
